Pedestal Technology Joins Phizzle's Partner Program; Two Companies Aim to Open Pharma to Digitization/AI
- Written by Newsfile
San Francisco, California--(Newsfile Corp. - October 19, 2023) - Phizzle, the leader in software used to automate data capture in biopharma applications, today announced a partner agreement with Pedestal Technology to bring Pedestal's best-in-class, mission-critical technology management to Phizzle's EDGMaker platform.
To view the full announcement, including downloadable images, bios, and more, click here[1].
Key Takeaways:
- Phizzle's EDGMaker Platform Partners with Leading Biopharma IT Firm
- Pair Aims to Standardize Scientific Lab Instrument Digitization and Automation
- EDGMaker is Biopharma Industry's Only Live Use Case of Instrument Automation, Currently Deployed at Merck
Click image above to view full announcement.
ABOUT PHIZZLEPhizzle's EDGMaker is the world's first and only scientific instrument platform to centrally manage drug production data. Our technology is unlocking the manufacturing potential of the pharmaceutical industry by bringing data standardization, instrument automation, and FDA-compliant digital record-keeping to critical drug production.
Learn more at www.phizzle.com[2]
Contacts:
Cecilie Carterccarter@phizzle.com[3]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/184545[5]
Learn more about Bill C-18[6] and how it will affect Canadian users when viewing news online.
References
- ^ click here (api.newsfilecorp.com)
- ^ www.phizzle.com (api.newsfilecorp.com)
- ^ ccarter@phizzle.com (www.newsfilecorp.com)
- ^ Phizzle (api.newsfilecorp.com)
- ^ https://www.newsfilecorp.com/release/184545 (api.newsfilecorp.com)
- ^ Learn more about Bill C-18 (www.newsfilecorp.com)